Nektar Therapeutics
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $4.8M | $59.6M | $55.6M | $12.4M | $39.1M | $25.4M | $15.3M | $17.8M |
| Accounts Receivable | $5.0M | $15.7M | $19.9M | $3.6M | $2.2M | $5.8M | $4.9M | $25.1M |
| Inventory | $10.7M | $11.1M | $11.3M | $13.0M | $13.5M | $18.3M | $12.7M | $7.3M |
| Total Current Assets | $326.8M | $426.0M | $350.1M | $288.2M | $257.9M | $314.6M | $276.7M | $354.0M |
| Property, Plant & Equipment | $47.5M | $65.6M | $71.3M | $70.4M | $67.0M | $72.2M | $78.6M | $89.8M |
| Goodwill | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $508.9M | $568.9M | $498.6M | $441.6M | $434.5M | $497.8M | $606.6M | $521.2M |
| Liabilities | ||||||||
| Accounts Payable | $4.8M | $2.8M | $2.4M | $2.7M | $9.1M | $2.9M | $3.0M | $7.2M |
| Total Current Liabilities | $56.2M | $72.2M | $61.2M | $64.0M | $98.2M | $78.5M | $275.5M | $64.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $421.0M | $480.7M | $492.2M | $405.3M | $524.4M | $450.8M | $408.7M | $430.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.12B | $-2.02B | $-1.87B | $-1.79B | $-1.73B | $-1.57B | $-1.40B | $-1.26B |
| Total Stockholders' Equity | $87.8M | $88.1M | $6.4M | $36.3M | $-89.9M | $47.0M | $197.8M | $90.7M |